Marcus A. Conant
Corporate Officer/Principal bij The University of California, San Francisco
Actieve functies van Marcus A. Conant
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - | - |
Loopbaan van Marcus A. Conant
Eerdere bekende functies van Marcus A. Conant
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | - | - |
| ENZO BIOCHEM, INC. | Directeur/Bestuurslid | - | - |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENZO BIOCHEM, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Marcus A. Conant
- Ervaring
